169 related articles for article (PubMed ID: 23114136)
1. [Methylation of FHIT gene promoter region in DNA from plasma of patients with myelodysplastic syndromes and demethylating effect of decitabine].
Deng YF; Zhang L; Zhang XQ; Hu MQ; Dai D; Zhang XZ; Xu YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1144-8. PubMed ID: 23114136
[TBL] [Abstract][Full Text] [Related]
2. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
3. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia.
Zheng S; Ma X; Zhang L; Gunn L; Smith MT; Wiemels JL; Leung K; Buffler PA; Wiencke JK
Cancer Res; 2004 Mar; 64(6):2000-6. PubMed ID: 15026336
[TBL] [Abstract][Full Text] [Related]
5. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.
Iwai M; Kiyoi H; Ozeki K; Kinoshita T; Emi N; Ohno R; Naoe T
Leukemia; 2005 Aug; 19(8):1367-75. PubMed ID: 15902282
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
Yang Y; Zhang Q; Xu F; Chang C; Li X
Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
[TBL] [Abstract][Full Text] [Related]
7. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Ye XS; Liu T; Cui X; Meng WT; Xi YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of hypermethylation of DLC-1 gene in myelodysplastic syndrome patients and effects of decitabine on DLC-1 gene expression].
Fu HY; Zhou HR; Yan JG; Chen CJ; Shen JZ
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(6):412-417. PubMed ID: 28219126
[No Abstract] [Full Text] [Related]
9. Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS.
Leone G; Voso MT; Teofili L; Lübbert M
Clin Immunol; 2003 Oct; 109(1):89-102. PubMed ID: 14585280
[TBL] [Abstract][Full Text] [Related]
10. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
[TBL] [Abstract][Full Text] [Related]
11. [p15(INK4B) methylation on prognosis and response to decitabine in patients with MDS].
Zhang Y; Song LX; Wu LY; Chang CK; Li X
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):237-41. PubMed ID: 23683424
[TBL] [Abstract][Full Text] [Related]
12. Decitabine treatment could ameliorate primary iron-overload in myelodysplastic syndrome patients.
Shucheng G; Chunkang C; Youshan Z; Juan G; Chengming F; Xi Z; Chao X; Xiao L
Cancer Invest; 2015 Apr; 33(4):98-106. PubMed ID: 25699651
[TBL] [Abstract][Full Text] [Related]
13. [Clinical observation of decitabine-treating patients with myelodysplastic syndrome and acute myeloid leukemia].
Yang H; Zhu HY; Jiang MM; Wang QS; Han XP; Huang WR; Jing Y; Wang SH; Zhang SS; Mei JH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):121-5. PubMed ID: 23484704
[TBL] [Abstract][Full Text] [Related]
14. [Clinical Value of p15, DAPK, SOCS1 and FHIT Genes Combined Detection in the Early Diagnosis and Prognosis Evaluation of Myelodysplastic Syndrome].
Deng CY; Chen S; Jiang M; Chen R; Nilupar T; Wang H; Hao JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1751-1755. PubMed ID: 29262910
[TBL] [Abstract][Full Text] [Related]
15. [Effect of 5-Aza-dC on FHIT gene expression in hepatocellular carcinoma cell line HepG2].
Li HL; Zhang WD; Li WT; Yin CG
Ai Zheng; 2009 Sep; 28(9):967-71. PubMed ID: 19728916
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Significance of ID4 Gene Mehtylation in Demethylation-Treated MDS Cell Line and 2 MDS Patients].
Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):455-9. PubMed ID: 25948204
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.
Yang Y; Zhang Q; Xu F; Wu L; He Q; Li X
J Cancer Res Clin Oncol; 2012 May; 138(5):729-37. PubMed ID: 22246278
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
Hackanson B; Robbel C; Wijermans P; Lübbert M
Ann Hematol; 2005 Dec; 84 Suppl 1():32-8. PubMed ID: 16292549
[TBL] [Abstract][Full Text] [Related]
19. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
[TBL] [Abstract][Full Text] [Related]
20. Demethylating agents in myeloid malignancies.
Garcia-Manero G
Curr Opin Oncol; 2008 Nov; 20(6):705-10. PubMed ID: 18841054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]